Ironwood Pharmaceuticals (IRWD) Capital Leases (2010 - 2018)

Ironwood Pharmaceuticals (IRWD) posted Capital Leases of $158000.0 for Q4 2018, up 652.38% sequentially from $21000.0 in Q1 2017.

Ironwood Pharmaceuticals (IRWD) Capital Leases (2010 - 2018) Analysis & Trends

Ironwood Pharmaceuticals has reported Capital Leases for 9 years, with the latest figure at $158000.0 in Q4 2018.

Quarterly Capital Leases changed N/A year-over-year to $158000.0 in Q4 2018, while the trailing twelve-month figure through Dec 2018 was $158000.0 (changed N/A YoY) and the FY2018 annual result came in at $158000.0, changed N/A from the prior year.
Capital Leases grew to $158000.0 in Q4 2018 per IRWD's latest filing, from $21000.0 in the prior quarter.
Over five years, Capital Leases peaked at $3.2 million in Q2 2014 and troughed at $21000.0 in Q1 2017.
A 5-year average of $1.3 million and a median of $687000.0 in 2015 frame the typical range for Capital Leases.
The sharpest annual moves came in 2014 and 2017: Capital Leases jumped 1494.95% in 2014, then sank 91.7% in 2017.
Over 5 years, Capital Leases stood at $2.6 million in 2014, then plunged by 88.1% to $306000.0 in 2015, then tumbled by 73.2% to $82000.0 in 2016, then sank by 74.39% to $21000.0 in 2017, then soared by 652.38% to $158000.0 in 2018.
According to Business Quant data, Capital Leases over the past three periods registered $158000.0, $21000.0, and $82000.0 for Q4 2018, Q1 2017, and Q4 2016 respectively.

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)
1	Haleon	43.94 Bn	42.97 Bn	-
2	Teva Pharmaceutical Industries	42.95 Bn	39.30 Bn	2.15 Bn
3	Zoetis	31.58 Bn	29.90 Bn	1.05 Bn
4	Takeda Pharmaceutical	28.63 Bn	22.83 Bn	5.10 Bn
5	United Therapeutics	22.16 Bn	19.49 Bn	683.80 Mn
6	Viatris	18.75 Bn	17.86 Bn	1.46 Bn
7	Neurocrine Biosciences	15.53 Bn	15.14 Bn	935.80 Mn
8	Elanco Animal Health	11.76 Bn	11.23 Bn	798.00 Mn
9	Dr Reddys Laboratories	10.11 Bn	9.95 Bn	-
10	Ironwood Pharmaceuticals	669.13 Mn	590.00 Mn	-

Download Data